PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06199934
- Locations
- 🇺🇸
Pfizer Global Headquarters, New York, New York, United States
A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT06190561
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
- Conditions
- Interventions
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 703
- Registration Number
- NCT06182124
- Locations
- 🇺🇸
Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States
🇺🇸Indago Research & Health Center, Inc, Hialeah, Florida, United States
🇺🇸IMA Clinical Research San Antonio, San Antonio, Texas, United States
A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
- Conditions
- Interventions
- First Posted Date
- 2023-12-21
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 100
- Registration Number
- NCT06179446
- Locations
- 🇺🇸
Research Centers of America ( Hollywood ), Hollywood, Florida, United States
🇺🇸Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
🇺🇸Research Centers of America, Hollywood, Florida, United States
A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2023-12-20
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 88
- Registration Number
- NCT06177457
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
🇺🇸Yale University/Magnetic Resonance Research Center (MRRC), New Haven, Connecticut, United States
🇧🇪Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06172348
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
- Conditions
- Interventions
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Pfizer
- Registration Number
- NCT06163677
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
- Conditions
- Interventions
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 400
- Registration Number
- NCT06163326
- Locations
- 🇺🇸
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
🇺🇸Alpesh D. Desai, DO PLLC, Houston, Texas, United States
🇯🇵Nagoya City University Hospital, Nagoya, Aichi, Japan
Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 33
- Registration Number
- NCT06153758
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1000
- Registration Number
- NCT06151418
- Locations
- 🇺🇸
Pfizer Inc, New York, New York, United States